Pemetrexed stability: additional information about microparticles.
作者信息
D'Huart Elise, Vigneron Jean, Morice Sophie, Lider Pauline, Demoré Béatrice
机构信息
Department of Pharmacy, Centre Hospitalier Universitaire de Nancy, Vandoeuvre-lès-Nancy, France.
出版信息
Eur J Hosp Pharm. 2019 Jan;26(1):56. doi: 10.1136/ejhpharm-2018-001570. Epub 2018 May 24.
Abstract
摘要
相似文献
1
Pemetrexed stability: additional information about microparticles.培美曲塞稳定性：关于微粒的更多信息。
Eur J Hosp Pharm. 2019 Jan;26(1):56. doi: 10.1136/ejhpharm-2018-001570. Epub 2018 May 24.
2
Physical and chemical stability of pemetrexed in infusion solutions.培美曲塞在输液溶液中的物理和化学稳定性。
Ann Pharmacother. 2006 Jun;40(6):1082-5. doi: 10.1345/aph.1G715. Epub 2006 May 23.
3
Physical and chemical stability of pemetrexed solutions in plastic syringes.培美曲塞溶液在塑料注射器中的物理和化学稳定性。
Ann Pharmacother. 2005 Dec;39(12):2026-8. doi: 10.1345/aph.1G161. Epub 2005 Oct 14.
4
A phase II study of pemetrexed in chemotherapy-naive elderly patients aged ≥ 75 years with advanced non-squamous non-small-cell lung cancer (HANSHIN Oncology Group 003).培美曲塞治疗化疗初治的 75 岁及以上高龄晚期非鳞非小细胞肺癌患者的 II 期临床研究（HANSHIN Oncology Group 003）。
Jpn J Clin Oncol. 2013 Dec;43(12):1184-9. doi: 10.1093/jjco/hyt159. Epub 2013 Oct 29.
5
Physical instability of frozen pemetrexed solutions in PVC bags.培美曲塞冻存溶液在聚氯乙烯袋中的物理不稳定性。
Ann Pharmacother. 2006 Jul-Aug;40(7-8):1289-92. doi: 10.1345/aph.1G558. Epub 2006 Jul 5.
6
A phase II open-label clinical study of comparing nab-paclitaxel with pemetrexed as second-line chemotherapy for patients with stage IIIB/IV non-small-cell lung cancer.一项比较纳布紫杉醇与培美曲塞作为 IIIB/IV 期非小细胞肺癌患者二线化疗的 II 期开放标签临床研究。
Med Oncol. 2015 Aug;32(8):216. doi: 10.1007/s12032-015-0660-5. Epub 2015 Jul 14.
7
Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study.尼妥珠单抗联合培美曲塞和顺铂一线治疗局部晚期或转移性非鳞状非小细胞肺癌患者（INSPIRE）：一项开放标签、随机、对照的 3 期研究。
Lancet Oncol. 2015 Mar;16(3):328-37. doi: 10.1016/S1470-2045(15)70046-X. Epub 2015 Feb 18.
8
Cost-effectiveness of continuation maintenance pemetrexed after cisplatin and pemetrexed chemotherapy for advanced nonsquamous non-small-cell lung cancer: estimates from the perspective of the Chinese health care system.顺铂和培美曲塞化疗后继续培美曲塞维持治疗晚期非鳞状非小细胞肺癌的成本效益：来自中国医疗保健系统视角的评估。
Clin Ther. 2013 Jan;35(1):54-65. doi: 10.1016/j.clinthera.2012.12.013.
9
Rationale and Design of PEMVITASTART-An Open-label Randomized Trial Comparing Simultaneous Versus Standard Initiation of Vitamin B and Folate Supplementation in Nonsquamous, Non-Small-cell Lung Cancer Patients Undergoing First-line Pemetrexed-based Chemotherapy.PEMVITASTART研究的原理与设计——一项开放性随机试验，比较非鳞状非小细胞肺癌患者在接受一线培美曲塞化疗时同时补充维生素B和叶酸与标准补充方式的效果
Clin Lung Cancer. 2017 Jul;18(4):432-435. doi: 10.1016/j.cllc.2016.11.017. Epub 2016 Dec 2.
10
Phase II study of pemetrexed as second or third line combined chemotherapy in patients with colorectal cancer.培美曲塞作为二线或三线联合化疗方案用于结直肠癌患者的II期研究。
Asian Pac J Cancer Prev. 2013;14(3):2019-22. doi: 10.7314/apjcp.2013.14.3.2019.
引用本文的文献
1
Stability of pemetrexed disodium in sodium chloride 0.9% w/v intravenous Viaflo infusion bags.培美曲塞二钠在 0.9%w/v 氯化钠静脉输液袋中的稳定性。
Eur J Hosp Pharm. 2023 Mar;30(e1):e2-e9. doi: 10.1136/ejhpharm-2021-002823. Epub 2021 Jul 16.
2
Stability of pemetrexed diarginine concentrates for solution in vials and diluted in 0.9% sodium chloride and dextrose 5% polyolefin infusion bags.培美曲塞二精氨酸浓缩物在小瓶中的稳定性，以及在 0.9%氯化钠和 5%聚烯烃葡萄糖输液袋中的稀释稳定性。
Eur J Hosp Pharm. 2022 Nov;29(6):353-358. doi: 10.1136/ejhpharm-2020-002620. Epub 2021 Mar 3.
本文引用的文献
1
Investigations into the physical and chemical stability of concentrated co-trimoxazole intravenous infusions.复方磺胺甲恶唑静脉输注浓溶液的物理和化学稳定性研究。
Eur J Hosp Pharm. 2018 Oct;25(e2):e102-e108. doi: 10.1136/ejhpharm-2017-001225. Epub 2017 Jul 19.
2
Physical and chemical stability of pemetrexed in infusion solutions.培美曲塞在输液溶液中的物理和化学稳定性。
Ann Pharmacother. 2006 Jun;40(6):1082-5. doi: 10.1345/aph.1G715. Epub 2006 May 23.
Zotero 插件